AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P901. A total of 3 filers reported holding AVANIR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $520,000 | -60.5% | 30,700 | -72.2% | 0.00% | 0.0% |
| Q3 2014 | $1,316,000 | +692.8% | 110,400 | +275.5% | 0.00% | – |
| Q2 2014 | $166,000 | -36.4% | 29,400 | -58.7% | 0.00% | – |
| Q1 2014 | $261,000 | +42.6% | 71,200 | +30.9% | 0.00% | – |
| Q4 2013 | $183,000 | +19.6% | 54,400 | +50.7% | 0.00% | – |
| Q3 2013 | $153,000 | +206.0% | 36,100 | +234.3% | 0.00% | – |
| Q2 2013 | $50,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,382 | $2,839,000 | 0.11% |
| GROUP ONE TRADING, L.P. | 575,100 | $6,855,000 | 0.11% |
| Citadel Advisors | 110,400 | $1,316,000 | 0.00% |